Steve Anderson

Steve Anderson - Director of Product Management, Trademark Solutions: Ensure the commercial success of Corsearch products and services leveraging product and industry knowledge and a user-based design approach. Years Experience: 24+ Areas of Expertise: Product design and development, trademarks research and prosecution, pharmaceuticals, work-flow automation First job I ever had? Dishwasher at a Greek restaurant when I was 13 years old. One thing that would surprise people most about me: I am a musician (trumpet/sax) and still perform with groups as a hobby 3 things I care about: Technology, trademarks, and creative solutions Sites/Blogs I like: The Great Geek Manual, The Science of Fiction, Weird Warp, and Bad Brand Good Brand

Email: steve.anderson@wolterskluwer.com

Author's Posts

The Importance of Brand Clearance: How About “COVFEFE” As a Brand? Part 2

by Steve Anderson on Thursday, 22 June, 2017

In our last installment, we put a critical eye to COVFEFE as a potential brand and attempted to deconstruct it in terms of potential meaning. In this installment, we’ll look at how COVFEFE would have fared had it been cleared as a potential brand in the fashion and food/beverage industries.

Using our visualization tool, Corsearch FOCUS, which determines phonetic and appearance-based similarity and relevancy algorithmically, let’s look at the preliminary clearance patterns for COVFEFE in the clothing and luxury goods industry. Corsearch FOCUS plots the mark on a radar-like visualization, giving an aerial view to pinpoint the most relevant data.

Read More

Topics: brands, branding, names

The Importance of Naming: How About “COVFEFE” As a Brand? Part 1

by Steve Anderson on Wednesday, 14 June, 2017

Interesting marks often come from unexpected places. Take the recent “COVFEFE” craze, based on an apparent typo in a tweet early May 31, 2017 by a certain “high profile” individual. In less than two weeks, there are now about 40 COVFEFE trademark applications filed worldwide, thousands of domains registered, and untold numbers of social media hits still happening around the clock.

Corsearch’s GeoMapping feature shows where known marks containing the term COVFEFE are currently filed throughout the world:

The COVFEFE mark is rapidly seizing the globe like a game of Risk®. We’re going to ignore COVFEFE’s humble origins for now and take a look at it from a pure “brand” perspective.

Read More

Topics: brands, branding, trademark

Data Visualization: A Picture Really is Worth a Thousand Words

by Steve Anderson on Friday, 19 May, 2017

Let’s face it—poring through data is tedious. People who have jobs where they have to comb through long linear lists of data—like trademark practitioners—endure hours of intense, painstaking work.

Data on its own doesn’t provide insights—it’s the way it’s gathered, organized, analyzed, and presented that gives it value. Whether it’s sports statistics, sales figures, or trademark registrations, data tells a story. Today, more and more organizations are using data visualization to tell their stories.

The human brain processes visuals 60,000 times faster than text and it’s more accustomed to processing images since most of the information that’s sent to our brains is visual. So it should come as no surprise that we’re able to make sense of data faster from an image.

Read More

Topics: trademarks, trademark clearance

Side Effect Warning: FDA’s “Change of Formulation” to POCA Algorithm May Cause Headaches, Tiredness, and Blurry Vision

by Steve Anderson on Wednesday, 5 April, 2017

Back in late 2016, the US Food and Drug Administration (FDA) released a new version of the Phonetic and Orthographic Computer Analysis (POCA) program called POCA 4.0. For those of us in the pharmaceutical trademark clearance and/or branding industries, this sounded like a good thing.

Program version updates come with the expectation of improvement. The original POCA was released years ago, and while not perfect, it remains the pharma industry standard in terms of ranking pharmaceutical marks on name safety similarity to a proposed candidate. POCA isn’t a definitive tool, and it’s just one of many methods and tools in the FDA’s arsenal for determining name safety issues in the pharmaceutical industry.

The POCA 4.0 algorithm has indeed been dramatically changed from the original pre-4.0 version. According to the FDA, the orthographic component of the POCA algorithm was revised to better capture errors that are being reported due to the increased use of electronic prescribing. The algorithm has been revised to put more emphasis on the similarity that occurs at the beginning of a name — especially the first three letters and on exact letter matches — and also to emphasize where names share letters that are not consecutive.

Read More

Topics: trademark, pharmaceuticals

‘Are You Experienced’? Jimi Hendrix Estate in Trademark Dispute With Family Member, Again

by Steve Anderson on Tuesday, 28 March, 2017

Jimi Hendrix hasn’t been on the Forbes list of Top-Earning Dead Celebrities for several years (he nearly made the cut in 2015), but that doesn’t mean the musician’s estate isn’t still earning big money and staying busy to protect its IP.

Recently, two companies that were founded by Hendrix’s estate — Experience Hendrix LLC and Authentic Hendrix LLC — filed a trademark and copyright infringement suit in US District Court against Hendrix’s own brother, Leon, and another individual.

The lawsuit claims that Leon Hendrix and Andrew Pitsicalis were selling Hendrix-themed cannabis, food, and alcohol, including “Jimi’s Cannabis Collection: Purple Haze” and “Jimi’s Wines” for “their own personal gain” through a company called Purple Haze Properties LLC.

Read More

Topics: trademark

About

The title says it all. This is a blog about trademarks and brands, expanding the expertise and resources you’ve come to expect from Corsearch. From expert research tips to the inside scoop on productivity solutions, join the conversation about trademarks and brands.

Subscribe to Email Updates